XM
IART icon

XTX Markets’s Integra LifeSciences IART Stock Holding History

XTX Markets’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$275K Buy
+4,237
New +$228K 0.57% 64
2020
Q3 		– Sell
-8,544
Closed -$401K – 147
2020
Q2 		$401K Buy
+8,544
New +$420K 1.36% 9

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Markets's IART Position: Q4 2020 in Review

XTX Markets opened a new position in Integra LifeSciences (IART) in Q4 2020: 4,237 shares worth $275K. The stake represents 0.57% of the portfolio and ranks #64 among its holdings. This is a return to the name: XTX Markets previously reported a position in IART as recently as Q2 2020.

XTX Markets first reported a position in IART in Q2 2020 and has held it in 2 quarters since. The position peaked at $401K in Q2 2020. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

  • XTX Markets held 4,237 shares of Integra LifeSciences worth $275K as of Q4 2020.
  • Integra LifeSciences was a new XTX Markets position in Q4 2020.
  • Integra LifeSciences made up 0.57% of XTX Markets's portfolio in Q4 2020, its #64 holding.
  • XTX Markets first reported a position in Integra LifeSciences in Q2 2020 and has held it in 2 quarters since.
  • XTX Markets's Integra LifeSciences position peaked at $401K in Q2 2020.
  • 251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.